[1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 17, 2007, Pages 4791-4794

  Carta, Antonio ^a   Palomba, Michele ^a   Paglietti, Giuseppe ^a   Molicotti, Paola ^a   Paglietti, Bianca ^a   Cannas, Sara ^a   Zanetti, Stefania ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

In vitro antitubercular activity; MDR M. tuberculosis; Triazolo 4,5 h quinolones

Indexed keywords

ETHAMBUTOL; ISONIAZID; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; HUMAN; HUMAN CELL; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MODELS, CHEMICAL; MYCOBACTERIUM TUBERCULOSIS; QUINOLONES; TRIAZOLES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 34547553149     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.06.064     Document Type: Article

References (23)

1. Ginsburg A.S., Grosset J.H., and Bisha W.R. Lancet Infect. Dis. 3 (2003) 432
2. Alland D., Kalkut G.E., Moss A.R., McAdam R.A., Hahn J.A., Bosworth W., Drucker E., and Bloom B.R. N. Engl. J. Med. 330 (1994) 1710
3. Whalen C., Horsburgh C.R., Hom D., Lahart C., Simberkoff M., and Ellner J. Am. Respir. Crit. Care Med. 51 (1995) 129
4. WHO Global Tuberculosis Control Report, Geneva: World Health Organization, March 2002.
5. Styblo K. Indian J. Chest Dis. Allied Sci. 24 (1982) 101
6. British Medical Research Council, Treatment of pulmonary tuberculosis with para-aminosalicylic acid and Streptomycin, BMJ 1949, 2, 1521.
7. XDR-TB-a global threat, The Lancet 2006, 368, 964.
8. Maxwell A. Trends Microbiol. 5 (1997) 102
9. Sriam D., Bal T.R., Yogeeswari P., Radha D.R., and Nagaraja V. J. Gen. Appl. Microbiol. 52 (2006) 195
10. Shandil R.K., Jayaram R., Kaur P., Gaonkar S., Suresh B.L., Mahesh B.N., Jayashree R., Nandi V., Bharath S., and Balasubramanian V. Antimicrob. Agents Chemother. 51 (2007) 576
11. Lalloo U.G., Naidoo R., and Ambaram A. Curr. Opin. Pulm. Med. 12 (2006) 179
12. Sriram D., Yogeeswari P., Basha J.S., Radha D.R., and Nagaraja V. Biorg. Med. Chem. 13 (2005) 5774
13. Sanna P., Carta A., and Rahbar-Nikookar M.E. Eur. J. Med. Chem. 35 (2000) 535
14. Sanna P., Carta A., Gherardini L., and Rahbar-Nikookar M.E. Il Farmaco 57 (2002) 79
15. Carta A., Paglietti G., Rahbar-Nikookar M.E., Sanna P., Sechi L., and Zanetti S. Eur. J. Med. Chem. 37 (2002) 355
16. Carta A., Loriga M., Paglietti G., Mattana A., Fiori P.L., Mollicotti P., Sechi L., and Zanetti S. Eur. J. Med. Chem 39 (2004) 195
17. Sanna P., and Paglietti G. Il Farmaco 44 (1989) 609
18. Nuvole A., Sanna P., Paglietti G., Juliano C., Zanetti S., and Capucinelli P. Il Farmaco 44 (1989) 619
19. Sanna P., Carta A., Paglietti G., Zanetti S., and Fadda G. Il Farmaco 47 (1992) 1001
20. Milata V. Adv. Heterocycl. Chem. 78 (2001) 189
21. Carta A., Sanna P., Paglietti G., and Sparatore F. Heterocycles 55 (2001) 1133
22. Palaci M., Ueki S.Y.M., Sato D.N., Da Silva Telles M.A., Curcio M., and Silva E.A.M. J. Clin. Microbiol. 34 (1996) 762
23. NCCLS-National Committee for Clinical Laboratory Standards, Antimycobacterial susceptibility testing for Mycobacterium tuberculosis. Tentative standard M24-T, Villanova, PA, 1995.